由于化疗诱导的前列腺癌炎症导致骨转移的前列腺癌,可能会增加类风湿性关节炎风险
Jide He1, Zenan Liu1, Qianyang Ni1
1Department of Urology, Peking University Third Hospital, Beijing, China.
International journal of rheumatic diseases
|June 9, 2025
概括
前列腺癌的化疗与骨转移会导致慢性炎症,增加类风湿性关节炎的风险. 将抗炎疗法与化疗相结合可以减少这种炎症,从而有可能预防老年患者的关节损伤.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 慢性炎症是类风湿性关节炎 (RA) 发展的关键因素.
- 骨转移性前列腺癌 (PCa-BM) 在老年人中很常见,影响预后.
- 对PCa-BM的化疗可以诱导慢性炎症,可能增加RA风险和并发症.
研究的目的:
- 在前列腺癌患有骨转移 (PCa-BM) 患者的类风湿性关节炎 (RA) 中研究化疗诱导的慢性炎症风险.
- 评估抗炎干预措施在减轻这些影响方面的有效性.
主要方法:
- 利用体外和体内实验来评估PCa-BM中化疗的炎症反应.
- 引入抗炎干预措施来评估细胞因子调节.
- 分析了PCa-BM瘤微环境中的炎症和免疫变化.
主要成果:
- 化疗显著激活了PCa-BM瘤微环境中的炎症因素,包括TNF-α,IL-6,IL-10,IL-17A和p-STAT3.
- 抗炎干预显著降低了与RA相关的化疗诱导的慢性炎症细胞因子.
- 观察到与RA发展相关的炎症生物标志物升高.
结论:
- 结合抗炎药物和化疗有效地减少了瘤微环境的炎症,延迟了瘤的进展.
- 这种组合疗法缓解了慢性炎症性关节损伤,这表明它在控制RA风险方面发挥了作用.
- 建议老年PCa-BM患者有肌肉骨疾病来管理RA风险.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
712
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
712
Inflammation
61.8K
Overview
61.8K
Freezing Point Depression and Boiling Point Elevation
39.7K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
39.7K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
831
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
831
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
618
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
618
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
605
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
605


